chr9-114330016-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_000608.4(ORM2):c.112C>T(p.Arg38Trp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000772 in 1,580,670 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R38Q) has been classified as Likely benign.
Frequency
Consequence
NM_000608.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ORM2 | NM_000608.4 | c.112C>T | p.Arg38Trp | missense_variant, splice_region_variant | 1/6 | ENST00000431067.4 | NP_000599.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ORM2 | ENST00000431067.4 | c.112C>T | p.Arg38Trp | missense_variant, splice_region_variant | 1/6 | 1 | NM_000608.4 | ENSP00000394936 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000130 AC: 19AN: 145756Hom.: 0 Cov.: 20
GnomAD3 exomes AF: 0.000127 AC: 27AN: 212394Hom.: 0 AF XY: 0.000139 AC XY: 16AN XY: 115240
GnomAD4 exome AF: 0.0000718 AC: 103AN: 1434822Hom.: 1 Cov.: 29 AF XY: 0.0000997 AC XY: 71AN XY: 712162
GnomAD4 genome AF: 0.000130 AC: 19AN: 145848Hom.: 0 Cov.: 20 AF XY: 0.000155 AC XY: 11AN XY: 71126
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at